Tonix Pharmaceuticals Names Mark T. Edgar, PhD as Senior VP of Product Development

Tonix Pharmaceuticals Holding Corp.

has appointed Mark T. Edgar, PhD to the newly-created position of Senior Vice President of Product Development. Dr. Edgar brings to Tonix over 25 years of experience in pharmaceutical development and commercialization. He has extensive expertise in advancing research-stage pharmaceutical candidates to commercialization, and has authored chemistry, manufacturing, and controls (CMC) strategies for numerous drug development programs. He joins Tonix from M.T. Edgar Consulting, where he provided pharmaceutical development support for over 46 companies, including Tonix, across a wide variety of formulations and therapeutic indications since founding the firm in 2003. From 1995 to 2003, Dr. Edgar held several executive level management positions in the biopharmaceutical industry, including Executive Vice President of Ancile Pharmaceuticals, Senior Vice President of Product Development of La Jolla Pharmaceutical Company, and Vice President of Development Research of Syntex Corporation, where he began his industry career as a research chemist. Dr. Edgar commented, "I look forward to working even more closely with the Tonix team as we advance the company's candidates through Phase 3 registration studies in